Malignant ependymoma is a rare tumor that develops in the brain or spinal cord. When it becomes cancerous, it requires careful treatment planning that often combines surgery, radiation, and sometimes experimental therapies being tested in clinical trials around the world.

How Treatment Helps Control Malignant Ependymoma

Treatment for malignant ependymoma aims to remove or shrink the tumor, slow down its growth, and help patients maintain the best possible quality of life. Because these tumors can press on important parts of the brain or spinal cord, treatment decisions depend heavily on where the tumor is located, how fast it is growing, and the patient’s overall health condition.^[1][2]

Medical teams usually classify ependymomas into grades based on how abnormal the cells look under a microscope. Grade 3 ependymomas are malignant, meaning they are cancerous and grow quickly. These tumors occur most often in the brain but can also appear in the spine. They are more aggressive than lower-grade tumors and have a higher chance of coming back after treatment.^[2][11]

Standard treatments approved by medical societies include surgery and radiation therapy. However, doctors and researchers continue to explore new therapies through clinical trials. These studies test innovative approaches that may work better or cause fewer side effects than current treatments. Some patients may be eligible to participate in these trials, depending on their specific situation and where they receive care.^[14][17]

Because malignant ependymoma is rare, treatment works best when managed by a specialized team that includes neurosurgeons, radiation oncologists, and other experts who understand this particular type of tumor. The rarity of the disease also means that not all doctors see many cases, which is why seeking care at centers experienced in treating ependymoma can make a significant difference.^[17][13]

Standard Treatment Approaches

Surgery: The First Line of Defense

Surgery is the most important treatment for malignant ependymoma. A specialized brain surgeon, called a neurosurgeon, performs an operation to remove as much of the tumor as possible. The goal is to achieve what doctors call a gross total resection, which means removing the entire visible tumor. Studies have shown that the extent of tumor removal is one of the most important factors affecting how well patients do in the long term.^[14][18]

However, complete removal is not always possible. Sometimes the tumor grows near sensitive areas of the brain or spinal cord that control vital functions like movement, breathing, or speech. Trying to remove tumor tissue from these areas could cause serious harm, such as paralysis or loss of function. In these situations, the surgeon removes as much tumor as safely possible, knowing that additional treatments will be needed afterward.^[6][15]

The surgery itself involves opening the skull (called a craniotomy) if the tumor is in the brain, or entering through the spine if the tumor is located there. The tissue removed during surgery is sent to a laboratory where specialists examine it under a microscope to confirm the diagnosis and determine the exact type and grade of ependymoma. This information helps guide decisions about further treatment.^[14][15]

Recovery from surgery varies depending on the tumor’s location and the patient’s overall health. Some patients may need physical therapy to regain strength and function, especially if the tumor was pressing on nerves or other important structures. The recovery period can range from weeks to months, and patients often need ongoing monitoring with brain scans to check for any signs of tumor regrowth.^[19][21]

Radiation Therapy: Targeting Remaining Tumor Cells

After surgery, most patients with malignant ependymoma receive radiation therapy. This treatment uses high-energy beams, similar to X-rays, to destroy any tumor cells that might remain after surgery. Radiation is particularly important when the surgeon could not remove the entire tumor or when there is a high risk that the tumor will come back.^[14][17]

Several different types of radiation therapy can be used. Conformal radiotherapy and intensity-modulated radiotherapy (IMRT) are techniques that use computers to shape the radiation beam precisely to match the tumor’s outline. This precision helps protect healthy brain tissue from unnecessary radiation exposure. Another option is proton beam radiotherapy, which may provide even better protection of normal tissues, though it is not available at all treatment centers.^[17][18]

Radiation treatment is typically given in small doses over several weeks. Patients usually receive treatment five days a week, with weekends off to allow the body to rest. Each treatment session lasts only a few minutes, though the entire appointment may take longer due to setup and positioning. The treatment itself is painless, but some patients experience side effects such as fatigue, skin irritation in the treatment area, or temporary hair loss if the radiation is directed at the brain.^[17]

The decision about whether to radiate only the area where the tumor was located or to include the entire brain and spinal cord depends on several factors. If tumor cells are found in the cerebrospinal fluid (the liquid that surrounds the brain and spinal cord), doctors may recommend broader radiation to prevent the cancer from spreading to other areas. This is called craniospinal irradiation.^[8][18]

Chemotherapy and Other Medical Treatments

Chemotherapy refers to medications that kill cancer cells or stop them from growing. Unlike some other brain tumors, chemotherapy is not a standard treatment for all patients with malignant ependymoma. It is most commonly used in specific situations, such as when the tumor has spread to other parts of the central nervous system or when it comes back after initial treatment.^[3][12]

Chemotherapy drugs can be given by mouth, through a vein, or sometimes directly into the cerebrospinal fluid. The specific drugs used depend on the patient’s age, the tumor’s characteristics, and whether this is the first treatment or treatment for recurrence. Because malignant ependymoma is rare, there is limited research showing which chemotherapy drugs work best, and responses can vary from patient to patient.^[17]

Side effects of chemotherapy depend on which drugs are used. Traditional chemotherapy drugs often cause temporary hair loss, nausea, vomiting, and a decrease in blood cell counts, which can make patients more susceptible to infections. Doctors monitor blood counts regularly during chemotherapy and can prescribe medications to help manage nausea and other side effects.^[18]

Some patients with malignant ependymoma may also need medications to manage symptoms caused by the tumor or its treatment. For example, corticosteroids like dexamethasone can reduce swelling around the tumor, which helps relieve symptoms such as headaches. Anticonvulsant medications may be prescribed if the patient experiences seizures. These supportive medications do not treat the tumor itself but help patients feel better and function more normally during treatment.^[9][18]

Innovative Treatments Being Tested in Clinical Trials

Because standard treatments do not work for all patients with malignant ependymoma, researchers around the world are studying new approaches. Clinical trials are carefully designed research studies that test whether a new treatment is safe and effective. Participating in a clinical trial may give patients access to promising therapies that are not yet available as standard treatment.^[17]

Understanding Clinical Trial Phases

Clinical trials for cancer treatments progress through different phases, each designed to answer specific questions. Phase I trials focus on safety, testing a new treatment in a small group of people to find out what dose is safe and what side effects might occur. Phase II trials include more patients and aim to determine whether the treatment actually works against the tumor. Phase III trials compare the new treatment with the current standard treatment to see which works better. Finally, Phase IV trials continue to monitor the treatment’s effects after it has been approved and is being used more widely.^[2]

For patients with malignant ependymoma, most clinical trials are in Phase I or Phase II because the disease is rare and there are still many unanswered questions about the best ways to treat it. Researchers are testing various innovative approaches, including new types of radiation therapy, different chemotherapy combinations, and entirely new classes of drugs.^[17]

Molecular-Targeted Therapies

Scientists have discovered that ependymomas are not all the same at the molecular level. Different tumors have different genetic changes that drive their growth. This has led to research into targeted therapies that aim at specific molecular pathways involved in tumor growth. Unlike traditional chemotherapy, which affects all rapidly dividing cells, targeted therapies are designed to interfere with specific proteins or genes that cancer cells need to survive.^[10][13]

For example, some ependymomas have abnormalities in genes called RELA or YAP1, which promote tumor formation and growth. Researchers are developing drugs that might block these abnormal proteins. Other studies are looking at drugs that prevent the formation of new blood vessels that tumors need to grow, a process called angiogenesis. While these approaches show promise in laboratory studies, they are still being tested in early clinical trials to determine if they are safe and effective in patients.^[6][13]

Immunotherapy Approaches

Immunotherapy is a type of treatment that helps the body’s own immune system recognize and attack cancer cells. This approach has shown remarkable success in treating some types of cancer, and researchers are now exploring whether it might help patients with ependymoma. Some immunotherapy drugs work by blocking signals that cancer cells use to hide from the immune system, while others help boost the immune system’s overall response to cancer.^[19]

Clinical trials are testing whether immunotherapy drugs that have worked for other cancers might also benefit patients with malignant ependymoma. Because these treatments are still experimental for this tumor type, they are only available through participation in research studies. Early results have been promising in some patients, but more research is needed to understand which patients are most likely to benefit.^[19]

Novel Radiation Techniques

Beyond standard radiation therapy, researchers are studying more advanced radiation techniques. One example is stereotactic radiosurgery, which delivers a very high dose of precisely focused radiation in just one to three treatment sessions instead of the several weeks required for conventional radiation. This technique may be useful for treating small tumors or tumors that have returned after initial treatment.^[17]

Studies are comparing different radiation methods to find out which provides the best tumor control with the fewest side effects. For instance, some trials are specifically looking at proton beam therapy versus standard X-ray radiation to determine whether protons truly offer advantages for ependymoma patients, particularly children whose developing brains may be more sensitive to radiation damage.^[18]

Participation in Clinical Trials

Not every patient is eligible for every clinical trial. Trials have specific requirements, called eligibility criteria, which may include factors such as the tumor’s location, whether the patient has received previous treatment, age, and overall health status. Some trials are only open at certain hospitals or cancer centers, which may require patients to travel for treatment.^[17]

Patients interested in clinical trials should discuss this option with their medical team. Doctors can help search for appropriate trials and explain the potential benefits and risks of participation. Many trials are conducted at major cancer centers in the United States, Europe, and other countries. Some organizations maintain databases of ongoing trials that patients and doctors can search by tumor type and location.^[2]

Most Common Treatment Methods

• Surgery (Neurosurgery)
  • Performed by a neurosurgeon to remove as much tumor as possible from the brain or spinal cord
  • Goal is gross total resection, removing all visible tumor tissue
  • May require craniotomy for brain tumors or spinal surgery for spinal cord tumors
  • Extent of surgical removal is the most important factor for long-term outcomes
  • Complete removal may not be possible if tumor is near critical structures
• Radiation Therapy
  • Uses high-energy beams to destroy remaining tumor cells after surgery
  • Includes conformal radiotherapy and intensity-modulated radiotherapy (IMRT) for precise targeting
  • Proton beam radiotherapy may provide additional protection of normal tissues
  • Stereotactic radiosurgery delivers high-dose radiation in one to three sessions for small or recurrent tumors
  • Typically given five days per week over several weeks
  • May include craniospinal irradiation if tumor has spread through cerebrospinal fluid
• Chemotherapy
  • Medications that kill cancer cells or stop their growth
  • Not standard for all malignant ependymoma patients, used selectively
  • Most commonly used when tumor has spread or returned after initial treatment
  • Can be given orally, intravenously, or directly into cerebrospinal fluid
  • Limited evidence for which chemotherapy drugs work best for ependymoma
• Targeted Therapy (Experimental)
  • Drugs designed to target specific molecular abnormalities in tumor cells
  • Focus on blocking proteins like RELA or YAP1 that promote tumor growth
  • Include drugs that prevent new blood vessel formation (anti-angiogenesis)
  • Currently available primarily through clinical trials
  • May cause different side effects than traditional chemotherapy
• Immunotherapy (Experimental)
  • Treatments that help the immune system recognize and attack cancer cells
  • Being tested in clinical trials for malignant ependymoma
  • May block signals cancer cells use to hide from immune system
  • Some patients show promising responses in early studies
  • Available only through participation in research studies
• Supportive Medications
  • Corticosteroids (like dexamethasone) to reduce swelling around tumor
  • Anticonvulsant medications to prevent or control seizures
  • Do not treat tumor directly but manage symptoms and improve quality of life